Power of One Campaign

Partnership objective

Help accelerate progress in the fight against malaria and help close the treatment gap in Africa.

Malaria is one of the top killers of kids on the planet. Malaria is one of the top killers of kids on the planet. Copyright Malaria No More

What are the health needs and challenges?

Malaria is one of the top 3 killers of children worldwide. Every 60 seconds, a child dies from this preventable and curable disease—90% of these children live in Africa.

Malaria keeps more children out of school than any other disease and keeps adults out of work, leading to billions of dollars drained out of the African economy.

There has been global progress in the fight against malaria but a USD 3.6 billion funding gap for malaria control must be closed to ensure progress toward the elimination of this disease and prevent the gains made from being reversed.

Description of partnership activities and how they address needs and challenges

Teaming up with several partners including Novartis and Alere, Malaria No More’s “Power of One” is a global digital fundraising campaign enabling the broad public to donate malaria treatments for children in Africa. Every dollar donated buys and delivers a full treatment course for a child with malaria.

Novartis is the campaign’s exclusive treatment sponsor. The company is supporting the campaign financially and in 2014, for the second year in a row, will match up to 1 million treatments funded by the public.

The campaign provides rapid diagnostic tests to help diagnose malaria in remote settings and provides artemisinin-based combination therapies (ATCs) for children with confirmed cases of malaria.

Zambia is the initial focus of the Power of One campaign. Working with John Snow International, the Zambian Ministry of Health, the Peace Corps and PATH MACEPA, the campaign is stepping up national efforts to help the country achieve universal coverage of testing and treatment and drive down malaria morbidity and mortality. To date, two million treatments have been delivered to Zambia within the scope of the campaign. One million treatments were funded through public donations and Novartis matched these with a further one million treatments. 

Summary of impact and forward looking information

In 2014, for the second year in a row, Novartis is matching public donations with up to 1 million free donated antimalarial treatments, and is supporting the campaign financially. Through differential pricing, Malaria No More can source quality-assured antimalarial pediatric treatments from the suppliers it chooses. If sourced from Novartis, the company provides Coartem Dispersible without profit for purchase through the campaign.


That’s the Power of One

Novartis supports Power of One campaign

Partnership information

Company(ies) Novartis

Partner(s) Alere, John Snow Inc, PATH, US Peace Corps, Zambian Ministry of Health

Type of Partner(s) Government, NGOs, Other Business

Therapeutic Focus Infectious Diseases

Disease(s) Malaria

Program Type(s) Availability of Treatment - Differential Pricing, Availability of Treatment - Financial Support, Availability of Treatment - Product Donations, Health System Infrastructure - Outreach & Medical Services, Prevention Programs - Awareness & Outreach

Targeted Population(s) Children, General population, Marginalised / Indigenous People, Mothers, Patients in needs of treatment, People with low income

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Zambia

Start Date 2013

More information Malaria No More "Power of One"

Completed date 2015

« Novartis is a corporate pioneer...partnering on a range of innovative programs that have enabled access to essential medicines for hundreds of millions of people. »

Martin Edlund, CEO of Malaria No More